Biogen, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Biogen, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4439
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Biogen, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Biogen, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Biogen, Inc. (Biogen or ‘the company’) formerly known as Biogen Idec, is a biopharmaceutical company engaged in the discovery, development, manufacturing, and commercialization of therapies in the areas of hematology, neurology and immunology. The company’s key products include Tecfidera, Tysabri (natalizumab), Avonex (Interferon beta-1a) and Rituxan (rituximab). The company primarily operates in the US and Europe. Biogen is headquartered in Weston, Massachusetts, the US.

Scope

- Detailed information on Biogen, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Biogen, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Biogen, Inc. including a breakdown and examination of key business segments
- Intelligence on Biogen, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Biogen, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Biogen, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Biogen, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Biogen, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Biogen, Inc.: Company Overview 9
Biogen, Inc.: Overview and Key Facts 9
Biogen, Inc.: Overview 9
Biogen, Inc.: Key Facts 9
Biogen, Inc.: Key Employees 11
Biogen, Inc.: Key Employee Biographies 13
Biogen, Inc.: Major Products and Services 19
Biogen, Inc.: Company History 21
Biogen, Inc.: Management Statement 27
Biogen, Inc.: Locations and Subsidiaries 32
Biogen, Inc.: Key Competitors 33
Biogen, Inc.: Company Analysis 34
Biogen, Inc.: Business Description 34
Biogen, Inc.: SWOT Analysis 36
Biogen, Inc.: SWOT Overview 36
Biogen, Inc.: Strengths 36
Biogen, Inc.: Weaknesses 37
Biogen, Inc.: Opportunities 37
Biogen, Inc.: Threats 39
Biogen, Inc.: Corporate Financial Deals Activity 40
Biogen, Inc.: Financial Deals Overview 40
Biogen, Inc.: Targets and Partners 42
Biogen, Inc.: Top Deals 2014 – 2018YTD* 44
Biogen, Inc.: Advisors 45
Biogen, Inc.: Top Financial Advisors 45
Biogen, Inc.: Mergers and Acquisitions 46
Biogen, Inc.: Corporate Venturing 47
Biogen, Inc.: Partnership 48
Biogen, Inc.: Divestments 49
Biogen, Inc.: Recent Developments 50
Biogen, Inc.: News and Events Summary 50
Biogen, Inc.: Business Expansion 54
Biogen, Inc.: Contracts 54
Biogen, Inc.: Financial Deals 55
Biogen, Inc.: Financial Performance 55
Biogen, Inc.: Grants 56
Biogen, Inc.: Market Developments 56
Biogen, Inc.: Strategy and Operations 57
Appendix 58
Contact Us 58
Methodology 58
About MarketLine 59

List of Tables
Table 1: Biogen, Inc.: Key Facts
Table 2: Biogen, Inc.: Key Employees
Table 3: Biogen, Inc.: Locations and Subsidiaries
Table 4: Biogen, Inc.: Key Competitors
Table 5: Biogen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Biogen, Inc.: M&A Activity by Geography (TTM*)
Table 7: Biogen, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Biogen, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Biogen, Inc.: Targets and Partners
Table 10: Biogen, Inc.: Top Deals 2014 - 2018YTD*
Table 11: Biogen, Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Biogen, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Biogen, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Biogen, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 15: Biogen, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 16: Biogen, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 17: Biogen, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 18: Biogen, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 19: Biogen, Inc.: News and Events Summary
Table 20: Biogen, Inc.: Business Expansion
Table 21: Biogen, Inc.: Contracts
Table 22: Biogen, Inc.: Financial Deals
Table 23: Biogen, Inc.: Financial Performance
Table 24: Biogen, Inc.: Grants
Table 25: Biogen, Inc.: Market Developments
Table 26: Biogen, Inc.: Strategy and Operations

List of Figures
Figure 1: Biogen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Biogen, Inc.: M&A Activity by Geography (TTM*)
Figure 3: Biogen, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Biogen, Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Biogen, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Biogen, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Biogen, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Biogen, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Biogen, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 10: Biogen, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 11: Biogen, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Biogen, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Invicta Holdings Limited:企業の戦略・SWOT・財務情報
    Invicta Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Invicta Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Casey’s General Stores, Inc. (CASY):企業の財務・戦略的SWOT分析
    Casey's General Stores, Inc. (CASY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Vinnolit GmbH & Co KG:企業の戦略的SWOT分析
    Vinnolit GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • MLP SE (MLP):企業の財務・戦略的SWOT分析
    MLP SE (MLP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • ALPCO Diagnostics-医療機器分野:企業M&A・提携分析
    Summary ALPCO Diagnostics (ALPCO) is a lifescience company that imports and distributes immunoassay based products. The company’s products include immunoassays, chemiluminescent assays, flow cytometry reagents, purified antibodies, recombinant proteins, and HPLC and MS-MS reagents. It also provides …
  • Singapore Petroleum Co Ltd:企業の戦略的SWOT分析
    Singapore Petroleum Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Saskatchewan Telecommunications Holding Corporation:企業の戦略的SWOT分析
    Saskatchewan Telecommunications Holding Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key compe …
  • Central Electricity Generating Co:企業の戦略的SWOT分析
    Central Electricity Generating Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Patterson-UTI Energy, Inc. (PTEN):石油・ガス:M&Aディール及び事業提携情報
    Summary Patterson-UTI Energy Inc (Patterson) is an oilfield service provider. It offers onshore contract drilling and pressure pumping services to oil and gas exploration and production companies. The company offers pressure pumping services such as well stimulation and cementing for completion of n …
  • Titan Machinery Inc (TITN):企業の財務・戦略的SWOT分析
    Titan Machinery Inc (TITN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • BioView Ltd (BIOV)-医療機器分野:企業M&A・提携分析
    Summary BioView Ltd (BioView) is a medical device company that develops, manufactures and markets automated cell imaging and analysis solutions, which incorporate proprietary imaging, analysis and review technology. The technology provides automatic control of fully motorized fluorescent and bright- …
  • Immunomedics Inc (IMMU):企業の財務・戦略的SWOT分析
    Immunomedics Inc (IMMU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • St. James’S Place Plc:企業の戦略・SWOT・財務分析
    St. James'S Place Plc - Strategy, SWOT and Corporate Finance Report Summary St. James'S Place Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • GeoVax Labs Inc (GOVX):製薬・医療:M&Aディール及び事業提携情報
    Summary GeoVax Labs Inc (GeoVax) develops human vaccines for diseases caused by human immunodeficiency virus (HIV), cancer and other infectious diseases using Modified Vaccinia Ankara Virus-Like Particle (MVA-VLP) vaccine platform. The company’s vaccine development programs focus on HIV, Zika virus …
  • IntegraGen SA (ALINT):医療機器:M&Aディール及び事業提携情報
    Summary IntegraGen SA (IntegraGen) is a developer and commercializer of molecular diagnostic tests for the treatment of autism and oncology. The company provides advanced genomic and bioinformatic services, including clinical research, basic and human genetic research, bioinformatics and bioanalysis …
  • Northwest Territories Power Corp:企業の戦略的SWOT分析
    Northwest Territories Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • EXINI Diagnostics AB:医療機器:M&Aディール及び事業提携情報
    Summary EXINI Diagnostics AB (EXINI), a subsidiary of Progenics Pharmaceuticals Inc, is a healthcare technology company that offers development of software solutions for the medical diagnostic market. The company offers aBSI, a web application used by trained healthcare professionals and researchers …
  • Landmark Graphics Corp:企業の戦略的SWOT分析
    Landmark Graphics Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Blirt SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Blirt SA (Blirt) is a biotechnology company that produces specialty enzymes utilized in nucleic acid for purification and sequencing. The company offers recombinant protein and molecular biology products. It provides protein products such as proteinases, RNase inhibitors, reverse transciptas …
  • Heidrick & Struggles International Inc (HSII):企業の財務・戦略的SWOT分析
    Summary Heidrick & Struggles International Inc (Heidrick & Struggles) is a provider of business advisory and consulting services. The company’s services comprise executive search, leadership consulting, and culture shaping services. Its leadership consulting services include leadership assessment an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆